Abstract
Due to the COVID-19 outbreak, routine clinical trial initiations and enrollments (except those for COVID-19) announced by many hospital institutions were suspended. Since mid-March, under the epidemic prevention and control efforts in China, many enterprises have resumed work and production in an orderly manner [1]. In a policy issued March 21, the Beijing Municipal Health Commission encouraged the resumption of daily medical services for all hospitals, while strengthening epidemic control work and announcing that patients with signs and symptoms of COVID-19 visit doctors in three specific hospitals [2].
Cite
CITATION STYLE
Wang, Z., Chen, G., Liu, X., Du, A., Li, M., & Wang, J. (2020). How to safely and smoothly resume trials after the COVID-19 outbreak. Journal of Global Health, 10(2), 1–4. https://doi.org/10.7189/jogh.10.020318
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
